A systematic review of microRNA expression profiling studies in human gastric cancer

Cancer Medicine

Volumn 3, Issue 4, 2014, Pages 878-888

  Shrestha, Sirjana ^a   Hsu, Sheng Da ^a   Huang, Wei Yun ^a   Huang, Hsi Yuan ^a   Chen, Wenliang ^a   Weng, Shun Long ^a,b,c,d   Huang, Hsien Da ^a,e  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biomarker; Gastric cancer; MicroRNA; MiRNA target genes

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 148A; MICRORNA 21; MICRORNA 223; MICRORNA 25; MICRORNA 375; MICRORNA 638; MICRORNA 92; SMALL UNTRANSLATED RNA; TUMOR MARKER; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ARTICLE; DOWN REGULATION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; PRIORITY JOURNAL; RNA ANALYSIS; RNA FOLDING; STOMACH CANCER; SYSTEMATIC REVIEW; UPREGULATION; ANIMAL; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; STOMACH NEOPLASMS;

ANIMALS; BIOMARKERS, TUMOR; EARLY DETECTION OF CANCER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84919882753     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.246     Document Type: Article

References (51)

1. Ferlay, J., H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin . 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893-2917.
2. Coburn, N. G. 2009. Lymph nodes and gastric cancer. J. Surg. Oncol. 99:199-206.
3. Konishi, H., D. Ichikawa, S. Komatsu, A. Shiozaki, M. Tsujiura, H. Takeshita, et al. 2012. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br. J. Cancer 106:740-747.
4. Li, B. S., Y. L. Zhao, G. Guo, W. Li, E. D. Zhu, X. Luo, et al. 2012. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 7:e41629.
5. Jiang, Z., J. Guo, B. Xiao, Y. Miao, R. Huang, D. Li, et al. 2010. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol. 45:17-23.
6. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
7. Esquela-Kerscher, A., and F. J. Slack . 2006. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269.
8. Alvarez-Garcia, I., and E. A. Miska . 2005. MicroRNA functions in animal development and human disease. Development 132:4653-4662.
9. Zhu, W., D. Zhu, S. Lu, T. Wang, J. Wang, B. Jiang, et al. 2012. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med. Oncol. 29:384-391.
10. Guo, J., Y. Miao, B. Xiao, R. Huan, Z. Jiang, D. Meng, et al. 2009. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 24:652-657.
11. Song, M. Y., K. F. Pan, H. J. Su, L. Zhang, J. L. Ma, J. Y. Li, et al. 2012. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 7:e33608.
12. Griffith, O. L., A. Melck, S. J. Jones, and S. M. Wiseman . 2006. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J. Clin. Oncol. 24:5043-5051.
13. Chan, S. K., O. L. Griffith, I. T. Tai, and S. J. Jones . 2008. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol. Biomarkers Prev. 17:543-552.
14. Carvalho, J., N. C. van Grieken, P. M. Pereira, S. Sousa, M. Tijssen, T. E. Buffart, et al. 2012. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J. Pathol. 228:31-44.
15. Kim, C. H., H. K. Kim, R. L. Rettig, J. Kim, E. T. Lee, O. Aprelikova, et al. 2011. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med. Genomics 4:79.
16. Li, X., F. Luo, Q. Li, M. Xu, D. Feng, G. Zhang, et al. 2011. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol. Rep. 26:1431-1439.
17. Li, X., Y. Zhang, H. Zhang, X. Liu, T. Gong, M. Li, et al. 2011. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9:824-833.
18. Oh, H. K., A. L. Tan, K. Das, C. H. Ooi, N. T. Deng, I. B. Tan, et al. 2011. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin. Cancer Res. 17:2657-2667.
19. Tchernitsa, O., A. Kasajima, R. Schafer, R. J. Kuban, U. Ungethum, B. Gyorffy, et al. 2010. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J. Pathol. 222:310-319.
20. Ding, L., Y. Xu, W. Zhang, Y. Deng, M. Si, Y. Du, et al. 2010. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 20:784-793.
21. Tsukamoto, Y., C. Nakada, T. Noguchi, M. Tanigawa, L. T. Nguyen, T. Uchida, et al. 2010. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 70:2339-2349.
22. Ueda, T., S. Volinia, H. Okumura, M. Shimizu, C. Taccioli, S. Rossi, et al. 2010. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 11:136-146.
23. Yao, Y., A. L. Suo, Z. F. Li, L. Y. Liu, T. Tian, L. Ni, et al. 2009. MicroRNA profiling of human gastric cancer. Mol. Med. Report 2:963-970.
24. Luo, H., H. Zhang, Z. Zhang, X. Zhang, B. Ning, J. Guo, et al. 2009. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res. 28:82.
25. Liu, T., H. Tang, Y. Lang, M. Liu, and X. Li . 2009. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 273:233-242.
26. Petrocca, F., R. Visone, M. R. Onelli, M. H. Shah, M. S. Nicoloso, I. de Martino, et al. 2008. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13:272-286.
27. Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103:2257-2261.
28. Hsu, S. D., F. M. Lin, W. Y. Wu, C. Liang, W. C. Huang, W. L. Chan, et al. 2011. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39:D163-D169.
29. Harris, M. A., J. Clark, A. Ireland, J. Lomax, M. Ashburner, R. Foulger, et al. 2004. The gene ontology (GO) database and informatics resource. Nucleic Acids Res. 32:D258-D261.
30. Kanehisa, M., S. Goto, S. Kawashima, Y. Okuno, and M. Hattori . 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32:D277-D280.
31. Dennis, G. Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, et al. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:P3.
32. Ma, Y., P. Zhang, J. Yang, Z. Liu, Z. Yang, and H. Qin . 2012. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int. J. Cancer 130:2077-2087.
33. Guan, P., Z. Yin, X. Li, W. Wu, and B. Zhou . 2012. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J. Exp. Clin. Cancer Res. 31:54.
34. Vosa, U., T. Vooder, R. Kolde, J. Vilo, A. Metspalu, and T. Annilo . 2013. Meta-analysis of microRNA expression in lung cancer. Int. J. Cancer 132:2884-2893.
35. Zhong, Z., Z. Dong, L. Yang, and Z. Gong . 2012. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J. Cancer Res. Clin. Oncol. 138:1781-1788.
36. Lee, J. A., H. Y. Lee, E. S. Lee, I. Kim, and J. W. Bae . 2011. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J. Breast Cancer 14:269-275.
37. Xu, X., Z. Chen, X. Zhao, J. Wang, D. Ding, Z. Wang, et al. 2012. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem. Biophys. Res. Commun. 421:640-645.
38. Nishida, N., M. Nagahara, T. Sato, K. Mimori, T. Sudo, F. Tanaka, et al. 2012. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin. Cancer Res. 18:3054-3070.
39. Shigoka, M., A. Tsuchida, T. Matsudo, Y. Nagakawa, H. Saito, Y. Suzuki, et al. 2010. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 60:351-357.
40. Scapoli, L., A. Palmieri, L. Lo Muzio L, F. Pezzetti, C. Rubini, A. Girardi, et al. 2010. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int. J. Immunopathol. Pharmacol. 23: 1229-1234.
41. Kurashige, J., M. Watanabe, M. Iwatsuki, K. Kinoshita, S. Saito, Y. Hiyoshi, et al. 2012. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. Br. J. Cancer 106:182-188.
42. Wang, F., Y. Li, J. Zhou, J. Xu, C. Peng, F. Ye, et al. 2011. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am. J. Pathol. 179:2580-2588.
43. Liffers, S. T., J. B. Munding, M. Vogt, J. D. Kuhlmann, B. Verdoodt, S. Nambiar, et al. 2011. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab. Invest. 91:1472-1479.
44. Zhao, X., R. Mohan, S. Ozcan, and X. Tang . 2012. MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic beta-cells. J. Biol. Chem. 287:31155-31164.
45. Nagahama, Y., M. Ishimaru, M. Osaki, T. Inoue, A. Maeda, C. Nakada, et al. 2008. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1. Cancer Sci. 99:23-30.
46. Sun, Y. S., Z. Y. Ye, Z. Y. Qian, X. D. Xu, and J. F. Hu . 2012. Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients. J. Exp. Clin. Cancer Res. 31:81.
47. Starczynowski, D. T., W. W. Lockwood, S. Delehouzee, R. Chari, J. Wegrzyn, M. Fuller, et al. 2011. TRAF6 is an amplified oncogene bridging the RAS and NF-kappaB pathways in human lung cancer. J. Clin. Invest. 121:4095-4105.
48. Kim, E. K., and E. J. Choi . 2010. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802:396-405.
49. Regalo, G., C. Resende, X. Wen, B. Gomes, C. Duraes, R. Seruca, et al. 2010. C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab. Invest. 90:1132-1139.
50. Liang, B., S. Wang, X. G. Zhu, Y. X. Yu, Z. R. Cui, and Y. Z. Yu . 2005. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J. Gastroenterol. 11:623-628.
51. Gong, X., R. Wu, H. Wang, X. Guo, D. Wang, Y. Gu, et al. 2011. Evaluating the consistency of differential expression of microRNA detected in human cancers. Mol. Cancer Ther. 10:752-760.